Pharma maker SSY reports HK$647m profit

Business | 18 Oct 2018 5:18 pm

Pharmaceuticals manufacturer SSY Group (2005) said net profit for the first nine months increased by 42 percent to HK$647 million from a year earlier, thanks to an increase in sales volumes and average selling prices of intravenous infusion solution.

The gross profit for the nine months was HK$1.91 billion, representing an increase of 64 percent as compared with the same period of 2017.

Turnover increased by 46 percent to HK$3.07 billion from a year ago.

Search Archive

Advanced Search
November 2018
S M T W T F S

Today's Standard



Yearly Magazine

Yearly Magazine